Patents by Inventor Christoph Rademacher

Christoph Rademacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Langerin+ cell targeting
    Patent number: 12290535
    Abstract: The present invention relates to the use of a vehicle for specific molecular targeting of Langerin+ cells, wherein the vehicle is capable of specifically binding to a Langerin+ cell, said vehicle comprising (a) at least one carrier and (b) at least one saccharide moiety-based conjugate for a targeted cargo delivery into a Langerin+ cell, as well as pharmaceutical compositions and uses comprising the inventive vehicle.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: May 6, 2025
    Assignees: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Humboldt-Universität zu Berlin
    Inventors: Christoph Rademacher, Eike-Christian Wamhoff, Jessica Schulze, Robert Carsten Willi Wawrzinek, Oliver Seitz, Gunnar Bachem
  • Langerin+ Cell Targeting
    Publication number: 20210047620
    Abstract: The present invention relates to the use of a vehicle for specific molecular targeting of Langerin+ cells, wherein the vehicle is capable of specifically binding to a Langerin+ cell, said vehicle comprising (a) at least one carrier and (b) at least one saccharide moiety-based conjugate for a targeted cargo delivery into a Langerin+ cell, as well as pharmaceutical compositions and uses comprising the inventive vehicle.
    Type: Application
    Filed: January 16, 2019
    Publication date: February 18, 2021
    Inventors: Christoph Rademacher, Eike-Christian Wamhoff, Jessica Schulze, Robert Carsten Willi Wawrzinek, Oliver Seitz, Gunnar Bachem